Effect of Vitamin D Supplementation According to Daily Dietary Levels on Biochemical Parameters in 25-Hydroxyvitamin D Deficiency of Women with Obesity.

Fatih Cesur, Zehra Nur Genç
{"title":"Effect of Vitamin D Supplementation According to Daily Dietary Levels on Biochemical Parameters in 25-Hydroxyvitamin D Deficiency of Women with Obesity.","authors":"Fatih Cesur, Zehra Nur Genç","doi":"10.4274/tjps.galenos.2024.37632","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This study examined how vitamin D supplementation based on daily dietary intake affects biomarkers in obese women with 25-hydroxyvitamin D deficiency.</p><p><strong>Materials and methods: </strong>Group D (n= 14) used vitamin D supplements daily for 2 months, and Group C (n= 16) did not receive supplements. Three blood samples were collected from the volunteers during the initial phase of the study. In this study, blood was collected from the volunteers: first measurement (M1), second measurement (M2), and third measurement (M3).</p><p><strong>Results: </strong>Compared with Group C, Group D had lower high-density lipoprotein (HDL) levels at M2 and fasting serum glucose (FSG) levels at M3 (<i>p</i> < 0.05), and lower HDL levels at M2 and FSG levels in normal-weight individuals at M3 (<i>p</i> < 0.05). In addition, 25-hydroxyvitamin D levels were higher in normal-weight women than in obese women according to M3 (<i>p</i>= 0.043). There was a higher negative correlation between HDL-C in M1 and FSG in Group D (r= -0.710, <i>p</i>= 0.004). 25-hydroxyvitamin D was moderately positively correlated with dietary vitamin D in M2 in Group D (r= 0.559, <i>p</i>= 0.038). Significant positive correlations were observed between iodine intake and triiodothyronine (T3) levels, whereas no significant difference was observed between thyroid-stimulating hormone and T3 levels.</p><p><strong>Conclusion: </strong>Vitamin D intake improves HDL levels in normal-weight individuals and causes an effect on FSG to be at the desired low level, whereas in individuals with obesity, although serum 25-hydroxyvitamin D levels increased in the last measurement, no effect was observed. Women with normal vitamin D levels have higher serum 25-hydroxyvitamin D levels than those who are obese.</p>","PeriodicalId":101423,"journal":{"name":"Turkish journal of pharmaceutical sciences","volume":"21 5","pages":"399-412"},"PeriodicalIF":2.0000,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11600319/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turkish journal of pharmaceutical sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/tjps.galenos.2024.37632","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: This study examined how vitamin D supplementation based on daily dietary intake affects biomarkers in obese women with 25-hydroxyvitamin D deficiency.

Materials and methods: Group D (n= 14) used vitamin D supplements daily for 2 months, and Group C (n= 16) did not receive supplements. Three blood samples were collected from the volunteers during the initial phase of the study. In this study, blood was collected from the volunteers: first measurement (M1), second measurement (M2), and third measurement (M3).

Results: Compared with Group C, Group D had lower high-density lipoprotein (HDL) levels at M2 and fasting serum glucose (FSG) levels at M3 (p < 0.05), and lower HDL levels at M2 and FSG levels in normal-weight individuals at M3 (p < 0.05). In addition, 25-hydroxyvitamin D levels were higher in normal-weight women than in obese women according to M3 (p= 0.043). There was a higher negative correlation between HDL-C in M1 and FSG in Group D (r= -0.710, p= 0.004). 25-hydroxyvitamin D was moderately positively correlated with dietary vitamin D in M2 in Group D (r= 0.559, p= 0.038). Significant positive correlations were observed between iodine intake and triiodothyronine (T3) levels, whereas no significant difference was observed between thyroid-stimulating hormone and T3 levels.

Conclusion: Vitamin D intake improves HDL levels in normal-weight individuals and causes an effect on FSG to be at the desired low level, whereas in individuals with obesity, although serum 25-hydroxyvitamin D levels increased in the last measurement, no effect was observed. Women with normal vitamin D levels have higher serum 25-hydroxyvitamin D levels than those who are obese.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
根据每日膳食水平补充维生素 D 对 25-羟维生素 D 缺乏症肥胖妇女生化指标的影响
研究目的本研究探讨了根据每日膳食摄入量补充维生素 D 如何影响缺乏 25- 羟基维生素 D 的肥胖妇女的生物标志物:D组(14人)每天服用维生素D补充剂,为期2个月;C组(16人)不服用补充剂。在研究的初始阶段,从志愿者身上采集了三份血液样本。在本研究中,志愿者的血液采集分为第一次测量(M1)、第二次测量(M2)和第三次测量(M3):与 C 组相比,D 组的高密度脂蛋白(HDL)水平(M2)和空腹血糖(FSG)水平(M3)均较低(P < 0.05),而正常体重者的高密度脂蛋白(HDL)水平(M2)和空腹血糖(FSG)水平(M3)均较低(P < 0.05)。此外,根据 M3,正常体重妇女的 25- 羟维生素 D 水平高于肥胖妇女(p= 0.043)。M1 组中的 HDL-C 与 D 组中的 FSG 之间存在较高的负相关(r= -0.710,p= 0.004)。D 组 M2 的 25-羟维生素 D 与膳食维生素 D 呈中度正相关(r= 0.559,p= 0.038)。碘摄入量与三碘甲状腺原氨酸(T3)水平之间呈显著正相关,而促甲状腺激素与 T3 水平之间无显著差异:维生素 D 的摄入可提高体重正常者的高密度脂蛋白水平,并使 FSG 达到理想的低水平,而对于肥胖症患者,虽然在最后一次测量中血清 25- 羟维生素 D 水平有所上升,但未观察到任何影响。维生素 D 水平正常的妇女的血清 25- 羟维生素 D 水平高于肥胖妇女。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Overcoming Intrinsic and Acquired Temozolomide Resistance in Glioblastoma: Fisetin as a Potential Strategy to Enhance Sensitivity via ZEB1 Modulation. Development and Optimization of Electrospun Poly(vinyl alcohol) Nanofibers for Vaginal Drug Delivery Using Design of Experiments Approach. Evaluation of Wound Healing Potential of (5-formylfuran-2-yl)Methyl Benzoates by In Vitro Cell Culture Studies. Perspectives and Experiences of Community Pharmacists on Vaccine and Cold Chain: A Qualitative Study. Development and Validation of High-Performance Thin Layer Chromatographic Method for the Simultaneous Estimation of Dapagliflozin and Vildagliptin in Fixed-Dose Combination.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1